is mounjaro a glp-1 agonist Weight Loss Treatments: Ozempic, Mounjaro, and Other Options| PMN What Foods and Drinks Are
Description
Front Immunol (2018) 9:1291

software, M.S

PubMed pubmed.ncbi.nlm.nih.gov [46] GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity PubMed pubmed.ncbi.nlm.nih.gov [47] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [48] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [49] GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations PubMed pubmed.ncbi.nlm.nih.gov [50] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [51] Adverse Effects of GLP-1 Receptor Agonists PubMed pubmed.ncbi.nlm.nih.gov [52] Use of glucagon-like-peptide 1 receptor agonist in the treatment of childhood obesity PubMed pubmed.ncbi.nlm.nih.gov [53] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point

Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong

10.1172/jci.insight.93091 [DOI] [PMC free article] [PubMed] 49.Folli F, La Rosa S, Finzi G, et al

doi: 10.1111/j.1463-1326.2011.01364.x
